Correlation Between Molecular Partners and NeOnc Technologies

Can any of the company-specific risk be diversified away by investing in both Molecular Partners and NeOnc Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and NeOnc Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Molecular Partners AG and NeOnc Technologies Holdings,, you can compare the effects of market volatilities on Molecular Partners and NeOnc Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of NeOnc Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and NeOnc Technologies.

Diversification Opportunities for Molecular Partners and NeOnc Technologies

0.27

Correlation Coefficient

Molecular Partners  NeOnc Technologies

Modest diversification

The 3 months correlation between Molecular and NeOnc is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and NeOnc Technologies Holdings, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NeOnc Technologies and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with NeOnc Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NeOnc Technologies has no effect on the direction of Molecular Partners i.e., Molecular Partners and NeOnc Technologies go up and down completely randomly.

Pair Corralation between Molecular Partners and NeOnc Technologies

Given the investment horizon of 90 days Molecular Partners AG is expected to under-perform the NeOnc Technologies. But the stock apears to be less risky and, when comparing its historical volatility, Molecular Partners AG is 2.91 times less risky than NeOnc Technologies. The stock trades about -0.04 of its potential returns per unit of risk. The NeOnc Technologies Holdings, is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  436.00  in NeOnc Technologies Holdings, on May 4, 2025 and sell it today you would earn a total of  39.00  from holding NeOnc Technologies Holdings, or generate 8.94% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Molecular Partners AG  vs.  NeOnc Technologies Holdings,

Molecular Partners

Risk-Adjusted Performance

Very Weak

Over the last 90 days Molecular Partners AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's essential indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

NeOnc Technologies

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in NeOnc Technologies Holdings, are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite fairly fragile technical indicators, NeOnc Technologies demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Molecular Partners and NeOnc Technologies

The main advantage of trading using opposite Molecular Partners and NeOnc Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, NeOnc Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeOnc Technologies will offset losses from the drop in NeOnc Technologies' long position.

The idea behind Molecular Partners AG and NeOnc Technologies Holdings, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.